Collateral sensitivity to gemcitabine (2′,2′-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines

Andries M. Bergman, Birgitte Munch-Petersen, Peter Buhl Jensen, Maxwell Sehested, Gijsbert Veerman, Daphne A. Voorn, Kees Smid, Herbert M. Pinedo, Godefridus J. Peters

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Collateral sensitivity to gemcitabine (2′,2′-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds